≤32 mL/min air diffusion at 3.45 bar (50 psig) and 23 °C (in water) 1200-2400 L process volume 3.4 bar max. differential pressure (50 psid) at 25 °C (Reverse) 5.5 bar max. differential pressure (80 psid) at 25 °C (Forward)
These products are manufactured in a facility which adheres to FDA Good Manufacturing Practices.
Directions for Use
Organism Retention: Retrovirus
Mode of Action: Filtration (size exclusion)
Application: Protein purification
Intended Use: Viral clearance
Instructions for Use: Please see the user guide (pg. 3) shipped with this product
Storage Statement: Store at room temperature
Disposal Statement: Dispose of in accordance with applicable federal, state and local regulations.
準備報告
Sterilization Method After wetting, may be autoclaved for 3 cycles of up to 60 min at 125 °C,
using liquid cycle, slow exhaust.
This product was manufactured with a Viresolve® membrane which meets the criteria for a "non-fiber releasing" filter as defined in 21 CFR 210.3 (b) (6).
分析報告
Gravimetric Extractables: after a 10 minute 1.5 LPM/ft² flush and 24 hours in water at controlled room temperature
Will meet the USP Oxidizable Substances Test requirements after a water flush of ≥8 L
法律資訊
VIRESOLVE is a registered trademark of Merck KGaA, Darmstadt, Germany